MedPath

Cell immunotherapy infusing HLA-haploidentical lymphocytes from a family member of non-HSCT donor

Not Applicable
Recruiting
Conditions
Relapsed malignancies or refractory viral diseases after allogeneic hematopoietic stem cell transplantation
Registration Number
JPRN-UMIN000014236
Lead Sponsor
Osaka Women's and Children's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

1. Acute GVHD Grade II or above. 2. Extensive chronic GVHD. 3. Physician's decision.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath